PO58 Drug interaction between curcuma and the antidepressant fluoxetine on behavioral despair and biochemical markers of kidney and liver function in Wistar rats

Authors

  • Jennifer Trujillo De Los Santos Universidad veracruzana
  • Jonathan Cueto Escobedo Departamento de Investigación Clínica y Traslacional, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, México
  • Juan Francisco Rodríguez Landa Laboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa, Veracruz, México
  • Gabriel Guillén Ruiz Programa de Investigadoras e Investigadores por México SECIHTI-Instituto de Neuroetología, Universidad Veracruzana, Xalapa, Veracruz, México
  • Ana Karen Limón Vázquez Laboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa, Veracruz, México
  • Eduardo Rivadeneyra Domínguez Facultad de Química Farmacéutica Biológica, Universidad Veracruzana, Xalapa, Veracruz, México
  • Olga Lidia Valenzuela Limón Facultad de Ciencias Químicas, Universidad Veracruzana, Orizaba, Veracruz, México

DOI:

https://doi.org/10.3407/2bsxyh35

Keywords:

fluoxetine, curcuma, antidepressants, food supplement

Abstract

Depression affects more than 300 million people worldwide, and its treatment includes SSRIs, but they have a prolonged latency. Research suggests that curcuma could be a therapeutic alternative. In this study, the interactions between curcuma and fluoxetine were evaluated. The results showed that curcuma, both individually and in combination with subthreshold doses of fluoxetine, had antidepressant effects without altering renal and hepatic function. However, in effective combinations, it cancels out the effect, which is related to a pharmacological interaction. These findings suggest that curcuma could be a natural option for treating depression.

Author Biography

  • Jennifer Trujillo De Los Santos, Universidad veracruzana

    Licenciada en Química Farmacéutica Bióloga y Maestra en Neuroetología por la Universidad Veracruzana, actualmente estudiante de Doctorado en Neuroetología. Experiencia bajo la línea de investigación de Neurofarmacología.

References

[1] STRINGARIS, A. (2017). What is depression?. J. Child Psychol. Psychiatry., 58 (12): 1287-1289. [DOI]

[2] COREA DEL CID, M.T. (2021). La depresión y su impacto en la salud pública. Rev. Méd. Hondur., 89 (Supl. 1): 46-52. [DOI]

[3] GONZÁLEZ-PARRA, D. et al. (2007). Tratamiento farmacológico de la depresión. Medicine., 9 (85): 5469-5477. [DOI]

[4] RODRÍGUEZ-LANDA, J.F. et al. (2003). Chronic, but not acute, clomipramine or fluoxetine treatment reduces firing rate of mesoaccumbens neurons of the rat. Neuropsychobiology., 48 (3):116-123. [DOI]

[5] RODRÍGUEZ-LANDA, J.F., et al. (2018). The aqueous crude extracts of Montanoa frutescens and Montanoa grandiflora reduce immobility faster than fluoxetine through GABAA receptors in rats forced to swim. J Evide Based Inte., 23: 1-12. [DOI]

[6] DAI, W., et al. (2022). Natural products for the treatment of stress-induced depression:

Pharmacology, mechanism, and traditional use. J Ethnopharmacol.,285:114692. [DOI].

[7] WANG, R. et al. (2008). The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur. J. Pharmacol., 578:43-50. [DOI].

[8] AL-JENOOBI, F.L. et al. (2015). Effect of Curcuma longa on CYP2D6 and CYP3A4 mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects. Eur. J. Drug. Metab. Pharmacokinet., 40: 61-66. [DOI].

Downloads

Published

2025-07-22

How to Cite

Trujillo De Los Santos, J., Cueto Escobedo, J., Rodríguez Landa, J. F., Guillén Ruiz, G., Limón Vázquez, A. K., Rivadeneyra Domínguez, E., & Valenzuela Limón, O. L. (2025). PO58 Drug interaction between curcuma and the antidepressant fluoxetine on behavioral despair and biochemical markers of kidney and liver function in Wistar rats. Revista Productos Naturales, 6(1), 201-205. https://doi.org/10.3407/2bsxyh35